Filing Details
- Accession Number:
- 0001209191-10-015511
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2010-03-09 12:00:00
- Reporting Period:
- 2009-12-31
- Filing Date:
- 2010-03-09
- Accepted Time:
- 2010-03-09 12:53:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131907 | Micromet Inc. | MITI | Biological Products, (No Disgnostic Substances) (2836) | 522243564 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1024004 | F David Hale | 1042-B North El Camino Real, Suite 430 Encinitas CA 92024 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2009-03-02 | 1,200 | $0.00 | 206,046 | No | 5 | G | Indirect | By Family Trust |
| Common Stock | Disposition | 2009-06-10 | 50,000 | $4.66 | 156,046 | No | 4 | S | Indirect | By Family Trust |
| Common Stock | Disposition | 2009-06-10 | 2,000 | $4.66 | 154,046 | No | 4 | S | Indirect | By son |
| Common Stock | Disposition | 2009-06-10 | 2,000 | $4.66 | 152,046 | No | 4 | S | Indirect | By daughter |
| Common Stock | Disposition | 2009-11-04 | 4,000 | $0.00 | 148,046 | No | 5 | G | Indirect | By Family Trust |
| Common Stock | Disposition | 2009-12-30 | 4,260 | $0.00 | 143,786 | No | 5 | G | Indirect | By Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Indirect | By Family Trust |
| No | 4 | S | Indirect | By Family Trust |
| No | 4 | S | Indirect | By son |
| No | 4 | S | Indirect | By daughter |
| No | 5 | G | Indirect | By Family Trust |
| No | 5 | G | Indirect | By Family Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 18,165 | Indirect | By LLC |
Footnotes
- By Hale Family Trust dated February 10, 1986.
- Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $4.60 to $4.76 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These securities are held by Hale BioPharma, LLC, a limited liability company controlled by the reporting person.
Billionaire Hedge Funds
